ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0921

Deep Immunologic Profiling of Trisomy 8-associated Autoinflammatory Disease (TRIAD)

Kalpana Manthiram1, Lihong Shi1, Yue Zhang2, Bayu Sisay3, Shouguo Gao4, Zhijie Wu4, Qin Xu1, Mary Bowes2, Laura Failla2, Neelam Redekar2, Abdel Elkahloun3, Pamela Schwartzberg1 and Daniel Kastner3, 1National Institute of Allergy and Infectious Disease, Bethesda, MD, 2National Institute of Allergy and Infectious Diseases, Bethesda, MD, 3National Human Genome Research Institute, Bethesda, MD, 4National Heart, Lung, and Blood Institute, Bethesda, MD

Meeting: ACR Convergence 2024

Keywords: Autoinflammatory diseases, immunology, Inflammation, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Trisomy 8 mosaicism is associated with an inflammatory disease characterized by recurrent fever and oral, genital, and gastrointestinal ulcers, resembling Behçet’s disease. Little is known about the immunologic profile of children with trisomy 8 mosaicism and inflammatory pathways involved in pathogenesis.

Methods: High dimensional flow cytometry was used to characterize peripheral blood mononuclear cells (PBMCs) of 12 subjects with trisomy 8 mosaicism and inflammatory disease and 13 age-matched healthy controls using a Cytek Aurora. Cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) was used to assess surface markers, transcriptome, and T cell and B cell receptor sequences at the single cell level in PBMCs of 6 subjects with trisomy 8 mosaicism and 3 controls. Analyses were performed in R.

Results: With high dimensional flow cytometry, we found that subjects with trisomy 8 mosaicism had a higher proportion of CD14++CD16– classical monocytes, which also had elevated expression of Ki67, CD64, IL-1β, IL-12p40, and CD169, a type 1 interferon (IFN) stimulated protein. In addition, trisomy 8 subjects had a higher frequency of CD4+ T cells and lower frequency of CD8+ T cells; both memory CD4+ and CD8+ T cells had lower expression of HLA-DR, an activation marker. With CITE-seq, we found that trisomy 8 subjects had expansion of classical monocyte populations with prominent IL1B and IFN stimulated gene expression. Moreover, we differentiated trisomy and disomy cells in trisomy 8 subjects using expression levels of chromosome 8 genes. We found that monocytes had a high proportion of trisomy 8 cells, which had higher expression of type I IFN, type II IFN, and IL-1β signaling pathways compared to healthy controls. However, among lymphocytes, naïve T cells had high levels of trisomy 8 cells, while their effector/memory counterparts had low levels. Trisomy 8 memory CD8+ T cells had lower expression of cytotoxic genes compared to disomy cells and healthy controls. Significantly fewer trisomy 8 cells were noted among expanded CD8+ memory T clones compared to unexpanded clones.

Conclusion: Trisomy 8 mosaicism is associated with an autoinflammatory disease we propose calling trisomy 8-associated autoinflammatory disease or TRIAD. We found expansion and activation of classical monocytes in TRIAD with involvement of IL-1β, IL-12-IFNγ, and type I IFN signaling pathways, which can be treatment targets. However, memory CD8+ T cells are less tolerant to trisomy 8, which affects their cytotoxic and proliferative abilities and may affect adaptive immune responses in these subjects.

This research was supported in part by the Division of Intramural Research of NIAID and NHGRI, NIH.


Disclosures: K. Manthiram: None; L. Shi: None; Y. Zhang: None; B. Sisay: None; S. Gao: None; Z. Wu: None; Q. Xu: None; M. Bowes: None; L. Failla: None; N. Redekar: None; A. Elkahloun: None; P. Schwartzberg: None; D. Kastner: None.

To cite this abstract in AMA style:

Manthiram K, Shi L, Zhang Y, Sisay B, Gao S, Wu Z, Xu Q, Bowes M, Failla L, Redekar N, Elkahloun A, Schwartzberg P, Kastner D. Deep Immunologic Profiling of Trisomy 8-associated Autoinflammatory Disease (TRIAD) [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/deep-immunologic-profiling-of-trisomy-8-associated-autoinflammatory-disease-triad/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/deep-immunologic-profiling-of-trisomy-8-associated-autoinflammatory-disease-triad/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology